Researchers will explore the use of tiny particles called extracellular vesicles to deliver chemotherapy drugs directly to hemangiosarcoma cancer cells to pave the way for the development of much-needed new treatments.
Researchers will use a novel approach to differentiate between cancerous and normal cells surrounding splenic hemangiosarcoma tumors to improve successful tumor removal and drug delivery.
Using data from the Golden Retriever Lifetime Study, researchers will study how inbreeding affects the genetics and health of dogs while also considering external factors, such as exercise and diet, on overall dog health.
Researchers will search for new therapy targets for hemangiosarcoma in dogs to inform the development of much-needed therapies and preventives for this deadly cancer.